[Time for booster doses against whooping cough for 10-year-old children]
- PMID: 16184889
[Time for booster doses against whooping cough for 10-year-old children]
Abstract
Acellular pertussis vaccine was introduced in Sweden in 1996 at the age of 3, 5 and 12 months, after a 17 year period without general vaccination against pertussis. At present, the incidence of notified pertussis has decreased to 1/10 of what was seen 10 years ago. In spite of the dramatic decrease, the disease is not eliminated. In accordance with the experience of other countries, most cases in Sweden are reported among older children and adults, while the highest risk of severe disease is still seen in infants. Many industrialized countries have introduced booster dose(s) in order to control the spread of pertussis. The Swedish National Board of Health and Welfare has recently initiated a major revision of the vaccines used and the schedule of the national vaccination program. Until the final proposal and in order not to miss the opportunity to boost pertussis immunity in children who were vaccinated as infants at the reintroduction of pertussis vaccination, the Board now recommends the Swedish municipalities as an interim measure to include pertussis in the current school booster against diphtheria and tetanus at 10 years of age with a full dose vaccine.
Comment in
-
[Why was whooping cough vaccination in Sweden interrupted between 1979-1996?].Lakartidningen. 2005 Sep 26-Oct 2;102(39):2788. Lakartidningen. 2005. PMID: 16245558 Swedish. No abstract available.
Similar articles
-
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759. Pediatrics. 2005. PMID: 16061582
-
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746. Pediatrics. 2006. PMID: 16950988
-
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28. Pediatrics. 2006. PMID: 16382131
-
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Expert Rev Vaccines. 2008. PMID: 18564017 Review.
-
Control of pertussis in the world.World Health Stat Q. 1992;45(2-3):238-47. World Health Stat Q. 1992. PMID: 1462658 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical